These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30398032)

  • 1. Use of cannabis and risk of advanced liver fibrosis in patients with chronic hepatitis C virus infection: A systematic review and meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Ungprasert P
    J Evid Based Med; 2018 Nov; 11(4):272-277. PubMed ID: 30398032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of caffeine in hepatitis C virus infection: a systematic review and meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Ungprasert P
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):17-22. PubMed ID: 27676091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.
    Hézode C; Roudot-Thoraval F; Nguyen S; Grenard P; Julien B; Zafrani ES; Pawlotsky JM; Dhumeaux D; Lotersztajn S; Mallat A
    Hepatology; 2005 Jul; 42(1):63-71. PubMed ID: 15892090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis.
    Farooqui MT; Khan MA; Cholankeril G; Khan Z; Mohammed Abdul MK; Li AA; Shah N; Wu L; Haq K; Solanki S; Kim D; Ahmed A
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):149-156. PubMed ID: 30234644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus infection and risk of osteoporotic fracture: A systematic review and meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Panjawatanan P; Ungprasert P
    J Evid Based Med; 2018 Feb; 11(1):20-25. PubMed ID: 29322660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis.
    Adejumo AC; Adegbala OM; Adejumo KL; Bukong TN
    Can J Gastroenterol Hepatol; 2018; 2018():9430953. PubMed ID: 30345261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
    Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
    J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression.
    Thein HH; Yi Q; Dore GJ; Krahn MD
    Hepatology; 2008 Aug; 48(2):418-31. PubMed ID: 18563841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort).
    Barré T; Nishimwe ML; Protopopescu C; Marcellin F; Carrat F; Dorival C; Delarocque-Astagneau E; Larrey D; Bourlière M; Petrov-Sanchez V; Simony M; Pol S; Fontaine H; Carrieri P;
    J Viral Hepat; 2020 Dec; 27(12):1473-1483. PubMed ID: 32810343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection and risk of Parkinson's disease: a systematic review and meta-analysis.
    Wijarnpreecha K; Chesdachai S; Jaruvongvanich V; Ungprasert P
    Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):9-13. PubMed ID: 29049127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update.
    Erman A; Krahn MD; Hansen T; Wong J; Bielecki JM; Feld JJ; Wong WWL; Grootendorst P; Thein HH
    BMJ Open; 2019 Nov; 9(11):e027491. PubMed ID: 31719068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.
    Kielland KB; Delaveris GJ; Rogde S; Eide TJ; Amundsen EJ; Dalgard O
    J Hepatol; 2014 Feb; 60(2):260-6. PubMed ID: 24096048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of common risk factors of fibrosis progression in chronic hepatitis C.
    Rüeger S; Bochud PY; Dufour JF; Müllhaupt B; Semela D; Heim MH; Moradpour D; Cerny A; Malinverni R; Booth DR; Suppiah V; George J; Argiro L; Halfon P; Bourlière M; Talal AH; Jacobson IM; Patin E; Nalpas B; Poynard T; Pol S; Abel L; Kutalik Z; Negro F
    Gut; 2015 Oct; 64(10):1605-15. PubMed ID: 25214320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hepatitis C virus genotype 3 in liver fibrosis progression--a systematic review and meta-analysis.
    Probst A; Dang T; Bochud M; Egger M; Negro F; Bochud PY
    J Viral Hepat; 2011 Nov; 18(11):745-59. PubMed ID: 21992794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol use disorders and the risk of progression of liver disease in people with hepatitis C virus infection - a systematic review.
    Llamosas-Falcón L; Shield KD; Gelovany M; Manthey J; Rehm J
    Subst Abuse Treat Prev Policy; 2020 Jun; 15(1):45. PubMed ID: 32605584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review.
    Dyal HK; Aguilar M; Bhuket T; Liu B; Holt EW; Torres S; Cheung R; Wong RJ
    Dig Dis Sci; 2015 Sep; 60(9):2813-24. PubMed ID: 26138651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of caffeine consumption in patients with chronic hepatitis C: A systematic review and meta-analysis.
    Jaruvongvanich V; Sanguankeo A; Klomjit N; Upala S
    Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):46-55. PubMed ID: 27350575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Jaruvongvanich V; Ahuja W; Wijarnpreecha K; Ungprasert P
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):694-697. PubMed ID: 28252464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking & risk of advanced liver fibrosis among patients with primary biliary cholangitis: A systematic review & meta-analysis.
    Wijarnpreecha K; Werlang M; Panjawatanan P; Pungpapong S; Lukens FJ; Harnois DM; Ungprasert P
    Indian J Med Res; 2021 Jun; 154(6):806-812. PubMed ID: 35662085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of hepatic fibrosis, cirrhosis, and mortality with cholecystectomy in patients with hepatitis C virus infection.
    Martin DJ; Weideman R; Crook T; Brown G
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):181-6. PubMed ID: 26566061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.